Theodore R Schroeder is of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 21,000 shares of PHAT, which is worth approximately $81,900. The most recent transaction as insider was on Apr 16, 2025, when has been sold 21,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K
n/a 3M change
n/a 12M change
Total Value Held $81,900

Theodore R Schroeder Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2025
BUY
Grant, award, or other acquisition
-
21,000 Added 50.0%
21,000 Common Stock

Also insider at

NBRV
Nabriva Therapeutics plc Healthcare
OTIC
OTONOMY, INC. Healthcare
CDTX
Cidara Therapeutics, Inc. Healthcare
TRS

Theodore R Schroeder

Fort Washington, PA

Track Institutional and Insider Activities on PHAT

Follow Phathom Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAT shares.

Notify only if

Insider Trading

Get notified when an Phathom Pharmaceuticals, Inc. insider buys or sells PHAT shares.

Notify only if

News

Receive news related to Phathom Pharmaceuticals, Inc.

Track Activities on PHAT